Live Breaking News & Updates on Cumulative Toxicity

Stay updated with breaking news from Cumulative toxicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Remaining Unmet Needs in the Third-Line and Lessons from HER2CLIMB

Drs Tripathy and Kaklamani emphasize the most critical unmet needs for patients with HER2+ metastatic breast cancer in the third-line or higher settings and recap what the field previously learned from the HER2CLIMB trial of tucatinib/trastuzumab/capecitabine. ....

Sara-hurvitz , Breast-cancer , Her2-breast-cancer , Her2-positive-breast-cancer , Metastatic-breast-cancer , Ther2 , Third-line-therapy , Brain-metastases , Cns-metastases , Neurotoxicity , Cumulative-toxicity